HER2 and hormone receptor conversion after neoadjuvant therapy for breast cancer
{{output}}
Background: The expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) in residual lesions may be different compared with primary tumors of the breast after neoadjuva... ...
